Sentences with phrase «global programs with»

Frankfurt - bound folks may want to give special consideration to the Tools of Change (TOC) Metadata Goes Global program with Brian O'Leary and Laura Dawson, and a very promising - sounding Publishers Launch event from Mike Shatzkin and Michael Cader.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

It's a full - time, four - year program delivered on campus, with an impressive global network and high - ranking faculty members.

Of the more than 600,000 global road traffic deaths that occur each year, China's comprise more than a third, with 220,000, according to Bloomberg's Global Road Safety Prglobal road traffic deaths that occur each year, China's comprise more than a third, with 220,000, according to Bloomberg's Global Road Safety PrGlobal Road Safety Program.

About Marriott Vacations Worldwide Corporation Marriott Vacations Worldwide Corporation is a leading global pure - play vacation ownership company, offering a diverse portfolio of quality products, programs and management expertise with over 65 resorts.

There's no longer any question that an education which equips a new graduate with the tools and technologies that it takes to join today's tech - and - data - centric workforce is far more likely to lead to solid earnings and long - term employment in our digital global economy than an expensive, traditional 4 - year program.

Oil prices jumped after Netanyahu said Israel has evidence that Iran lied about its nuclear program after signing the 2015 agreement with global powers.

Medical and recreational marijuana is a multi-billion dollar global industry, with various programs either ready to be implemented or already up and running in countries like Canada, Australia, Germany, Italy, and the Czech Republic.

Indeed, the H - 1B program helps us to compete with global companies, while making sure we have the brightest minds in the world working on our business.

His responsibilities included planning, executing and supervising an effective marketing and sales program along with creating educational concepts designed to expand the European and Asian customer base along with integrating the new Euro currency effectively into the clearing and settlement system at the global exchanges.

With a new $ 92 - million glass tower on the U of T campus, a program that typically leads the Canadian pack in global MBA rankings and a dean whose C.V. includes a stint as senior deputy governor at the Bank of Canada, it's not surprising that Rotman has a great reputation.

Thomas Sehested, CEO and co-founder of GAN integrity, a compliance technology platform, explains why these technologies are ineffective when it comes to global compliance efforts «Global compliance teams suffer because the technology offered to support compliance programs has been fragmented with activity - specific vendors, which hinders easy reporting and increases administrative headache and cost.&global compliance efforts «Global compliance teams suffer because the technology offered to support compliance programs has been fragmented with activity - specific vendors, which hinders easy reporting and increases administrative headache and cost.&Global compliance teams suffer because the technology offered to support compliance programs has been fragmented with activity - specific vendors, which hinders easy reporting and increases administrative headache and cost.»

Small class sizes that allow for personalized learning are a central element of Gustavson's appeal, along with a program that the university describes as «international at heart» — global business content is worked into the curriculum and there's a variety of international exchange possibilities.

In keeping with the program's focus on a global business outlook, students participate in an Executive Client Field Project, where they partner with a Canadian company looking to expand into India, China or Vietnam.

In Canada, for instance, a recently introduced Global Skills program allows tech workers to obtain work permits in just two weeks» time, compared with the roughly six months it would take to obtain an H - 1B visa stateside.

Traction: Reliefwatch ran its pilot program with Global Brigades in 42 health clinics across Honduras, Panama, and Nicaragua.

According to Sky News, the investment round is designed to fund Vice's global expansion, and a move into «scripted» or TV - style programming to go with its news and entertainment coverage.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

«Having access to this type of highly coveted content on Twitter will not only offer our users a unique programming schedule which will deepen their engagement with our platform but will also provide our sponsors with a value proposition that few other partners can bring to the table,» said Adam Bain, president of global revenue for Twitter in a press release.

According to CVI ² charter member and pioneering industry tracker and media company Global Corporate Venturing, today worldwide there are more than 1100 corporations with corporate venture programs, more than 475 of those having formed since the beginning of 2010.

NextAI is a global innovation program for artificial intelligence - related ventures, and talented teams from around the world are invited to Canada to leverage the nation's leadership in AI and are provided with capital, mentorship, education and networking opportunities.

«We're thrilled to be a part of the PayPal StartUp Blueprint program, as it directly aligns with our goal of helping early - stage startups compete in the global marketplace,» said Tom Bronfield, co-founder and managing director of Elevator.

He is currently the Director, New Program Development of R / GA Ventures where he works with global brands to develop in house, partner and accelerator programs.

Other highlights for the year included the introduction of GVBOT's Pillar Partners, the expansion of the Company of Young Professionals program to Richmond, North Vancouver, and the Tri-Cities, a new advocacy initiative with the Canadian Global Cities Council, and the WE FOR SHE Conference on gender diversity.

A performing arts program for teens in foster care, service dogs for children with disabilities and a global effort to help children in extreme poverty are among the 27 charities that will receive a $ 25,000 grant as winners of the Upstanders Challenge.

About Marriott Vacations Worldwide Corporation Marriott Vacations Worldwide Corporation is the leading global pure - play vacation ownership company offering a diverse portfolio of quality products, programs and management expertise with more than 60 resorts and more than 420,000 Owners and Members.

Creates a leading global luxury and upper - upscale vacation ownership operator with access to world - class loyalty programs and an expanded portfolio of highly demanded vacation destinations: Combining MVW and ILG will create a leading global vacation ownership and exchange company comprising approximately 650,000 owners, seven upper - upscale and luxury brands, over 100 vacation properties and more than 20,000 vacation ownership units around the world.

About Marriott Vacations Worldwide Corporation Marriott Vacations Worldwide Corporation is a leading global pure - play vacation ownership company, offering a diverse portfolio of quality products, programs and management expertise with 62 resorts.

Marriott Vacations Worldwide Corporation is a leading global pure - play vacation ownership company, offering a diverse portfolio of quality products, programs and management expertise with over 65 resorts.

The program provides traveler enrollment in TSA Precheck and in Global Entry, travel management company hours align with peak travel times and the travel program takes an omnichannel approach to accessing TMC support: telephone, online, mobile and chat.

The program has also partnered with The Working Group, a top web and mobile development shop in Toronto; Media Profile, one of Canada's most successful public relations firms; Global Accelerator Network, an international alliance of organizations that operate accelerator programs, championed by TechStars; and Postmedia Network Inc., the largest publisher of English daily newspapers in Canada.

About Marriott Vacations Worldwide Corporation Marriott Vacations Worldwide Corporation is a leading global pure - play vacation ownership company offering a diverse portfolio of quality products, programs and management expertise with more than 60 resorts and more than 420,000 Owners and Members.

Funded by Global Affairs Canada and managed by the Asia Pacific Foundation of Canada and the APEC Secretariat, the program is now nearing the end of its first year, with a focus on Vietnam.

Microsoft already been targeting startups through the Startup Zone (and related programs such as the Startup Accelerator), but Lewin says that was aimed at venture - backed companies with global ambitions.

With the objective of learning from the rich experiences and lessons that other countries have gained from small - and medium - sized enterprise (SME) export assistance programs, the Asia Pacific Foundation of Canada presents a new research report series, «Going Global.»

For the second year in a row, Kellogg's joint Executive MBA program with Hong Kong's UST Business School came out on top of The Financial Times» new 2010 global EMBA ranking released Oct. 26th.

I noted that the Italian BOND FUTURES Monday were trading above the June 27 close when ECB President Mario Draghi roiled global credit markets with his Sintra, Portugal speech, which suggested that the removal of a deflationary scare would allow the ECB to begin tapering its QE program.

Draper University designs and delivers world - class entrepreneurship and innovation education programs for a global audience with a future focus.

At EMD Serono, he was Senior Vice President and Global Senior Scientific Advisor in Immunology and Immuno - Oncology, facilitating major academic center alliances and running the CAR T - cell program in partnership with Intrexon.

The story does not end with EV subsidies either as Tesla has provided very generous residual buyback programs in key global markets like Hong Kong, which has very generous government incentives at the front end (fully detailed in the legacy post below) putting a Tesla Model S pricing nearly on top of a gas powered Honda Civic and well below a Mercedes entry model.

The international feedback loop of global central bank QE programs has provided the SNB with a massive windfall.

The meeting, Mr. Kim's first with another head of state, added a new layer of complexity to the global diplomacy around North Korea's nuclear program.

Now, in addition to expanding product offerings, Tmall Global wants to enhance the platforms «stickiness» by building membership programs for consumers in partnership with merchants, as well as an online community where mothers can share their knowledge and experiences.

As someone who lacked physical experience in the global workforce, the program's global business education equipped me with the tools I needed in order to succeed.

«I am convinced that it is this attitude that will attract some of the brightest minds in the Bitcoin world to study at the University of Nicosia especially with their Master's program in Digital Currency, another global first,» continued Rossouw.

Examples mentioned included the company's programs for spotting and taking down counterfeit - product listings from its online shopping sites, initiatives to simplify the trademark - registration process, reductions in the time it takes to remove counterfeit products, closer partnerships with global law enforcement authorities and governments, and the imposition of a variety of penalties against offending merchants, among others.

The Australian Program is part of the global Deloitte Technology Fast 500 program run in parallel with the United States, Canada, United Kingdom, France, Norway, Sweden, The Netherlands, Germany, Central Europe, Israel, South Africa, China, Hong Kong, India, Japan, Korea, Malaysia, New Zealand, Singapore, Taiwan and ThProgram is part of the global Deloitte Technology Fast 500 program run in parallel with the United States, Canada, United Kingdom, France, Norway, Sweden, The Netherlands, Germany, Central Europe, Israel, South Africa, China, Hong Kong, India, Japan, Korea, Malaysia, New Zealand, Singapore, Taiwan and Thprogram run in parallel with the United States, Canada, United Kingdom, France, Norway, Sweden, The Netherlands, Germany, Central Europe, Israel, South Africa, China, Hong Kong, India, Japan, Korea, Malaysia, New Zealand, Singapore, Taiwan and Thailand.

In its continuous effort to assist and also reward the Startup Community Z Nation Lab has partnered with IBM for its IBM Global Entrepreneur Program which equips Startups and Entrepreneurs with the go - to - market support, business mentorship, services,...

For those subscribers who are too busy to trade their own accounts we are now able to offer an Autotrading program with our SK OptionTrader service, as we are pleased to announce that we have entered into a partnership with Global AutoTrading and therefore auto trading is now available for SK OptionTrader signals

Artemis Capital Management LP selects candidates with a strong interest in global investments and trading with demonstrated talent in computer programming, data science, derivatives valuation, probability theory, and global macroeconomic thinking.